DCGI approves commercial launch of low cost Covid-19 test 'Feluda'

The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better ease of use.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: COVID-19 | Health